(Q36467686)

14 August 2017

title

(C2) Saliva, breast milk, and mucosal fluids in HIV transmission (English)

1 reference

14 August 2017

0 references

1 reference

K Page-Shafer

1

1 reference

14 August 2017

S Sweet

series ordinal

2

1 reference

14 August 2017

S Kassaye

series ordinal

3

1 reference

14 August 2017

C Ssali

series ordinal

4

1 reference

14 August 2017

publication date

1 April 2006

1 reference

Advances in Dental Research

14 August 2017

published in

1 reference

14 August 2017

volume

19

1 reference

14 August 2017

issue

1

1 reference

14 August 2017

page(s)

152-157

1 reference

Infection and AIDS in adult macaques after nontraumatic oral exposure to cell-free SIV.

14 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F154407370601900127

Persistent mitochondrial dysfunction in HIV-1-exposed but uninfected infants: clinical screening in a large prospective cohort.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154407370601900127

Estimating the timing of mother-to-child transmission of human immunodeficiency virus in a breast-feeding population in Kinshasa, Zaire

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154407370601900127

Breastfeeding by HIV-1-infected women and outcome in their infants: a cohort study from Durban, South Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154407370601900127

Early human immunodeficiency virus (HIV) infection in the HIV Network for Prevention Trials Vaccine Preparedness Cohort: risk behaviors, symptoms, and early plasma and genital tract virus load

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154407370601900127

Validation of a modified commercial enzyme-linked immunoassay for detection of human immunodeficiency virus type 1 immunoglobulin G antibodies in saliva

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154407370601900127

Late postnatal transmission of HIV-1 in breast-fed children: an individual patient data meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154407370601900127

Development of resistance mutations in women receiving standard antiretroviral therapy who received intrapartum nevirapine to prevent perinatal human immunodeficiency virus type 1 transmission: a substudy of pediatric AIDS clinical trials group prot

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154407370601900127

6-month efficacy, tolerance, and acceptability of a short regimen of oral zidovudine to reduce vertical transmission of HIV in breastfed children in Côte d'Ivoire and Burkina Faso: a double-blind placebo-controlled multicentre trial. DITRAME Study G

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154407370601900127

Mother-to-child transmission of human immunodeficiency virus type 1: report from the Nairobi Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154407370601900127

Evaluating the risk of HIV transmission through unprotected orogenital sex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154407370601900127

Two-dose intrapartum/newborn nevirapine and standard antiretroviral therapy to reduce perinatal HIV transmission: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154407370601900127

Late postnatal mother-to-child transmission of HIV-1 in Abidjan, Côte d'Ivoire

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154407370601900127

Characterization of nevirapine resistance mutations in women with subtype A vs. D HIV-1 6-8 weeks after single-dose nevirapine (HIVNET 012).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154407370601900127

Transmission of HIV-1 through breastfeeding among women in Dar es Salaam, Tanzania

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154407370601900127

Comparison of saliva and serum for HIV surveillance in developing countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154407370601900127

Use of antiretroviral drugs to prevent HIV-1 transmission through breast-feeding: from animal studies to randomized clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154407370601900127

Evaluation of a system using oral mucosal transudate for HIV-1 antibody screening and confirmatory testing. OraSure HIV Clinical Trials Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154407370601900127

Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154407370601900127

Identification of the K103N resistance mutation in Ugandan women receiving nevirapine to prevent HIV-1 vertical transmission.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154407370601900127

Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: 18-month follow-up of the HIVNET 012 randomised trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154407370601900127

Breast-feeding and Transmission of HIV-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154407370601900127

HIV-1 subtype C reverse transcriptase and protease genotypes in Zimbabwean patients failing antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154407370601900127

Risk factors for seroconversion to human immunodeficiency virus among male homosexuals. Results from the Multicenter AIDS Cohort Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154407370601900127

Breast-milk shedding of drug-resistant HIV-1 subtype C in women exposed to single-dose nevirapine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154407370601900127

Th1/Th2 cytokine expression in saliva of HIV-positive and HIV-negative individuals: a pilot study in HIV-positive individuals with oropharyngeal candidiasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154407370601900127

Postnatal transmission of HIV-1 after a maternal short-course zidovudine peripartum regimen in West Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154407370601900127

Do alternate modes for transmission of human immunodeficiency virus exist? A review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154407370601900127

Minimal risk of transmission of AIDS-associated retrovirus infection by oral-genital contact

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154407370601900127

Oral diagnostic testing for detecting human immunodeficiency virus-1 antibodies: a technology whose time has come.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154407370601900127

Cost effectiveness of single-dose nevirapine regimen for mothers and babies to decrease vertical HIV-1 transmission in sub-Saharan Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154407370601900127

Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154407370601900127

HIV transmission through breastfeeding: a study in Malawi

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154407370601900127

Pharmacokinetics of nevirapine in human immunodeficiency virus type 1-infected pregnant women and their neonates. Pediatric AIDS Clinical Trials Group Protocol 250 Team

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154407370601900127

A multicenter randomized controlled trial of nevirapine versus a combination of zidovudine and lamivudine to reduce intrapartum and early postpartum mother-to-child transmission of human immunodeficiency virus type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154407370601900127

A phase I/II study of the safety and pharmacokinetics of nevirapine in HIV-1-infected pregnant Ugandan women and their neonates (HIVNET 006).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154407370601900127

Sexual risk behavior and risk factors for HIV-1 seroconversion in homosexual men participating in the Tricontinental Seroconverter Study, 1982-1994.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154407370601900127

Risk of HIV infection attributable to oral sex among men who have sex with men and in the population of men who have sex with men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154407370601900127

Breast-milk infectivity in human immunodeficiency virus type 1-infected mothers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154407370601900127

Oral transmission of HIV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154407370601900127

Immunoprophylaxis to prevent mother-to-child transmission of HIV-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154407370601900127

Can HTLV-III be transmitted orally?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154407370601900127

Mastitis and immunological factors in breast milk of human immunodeficiency virus-infected women

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154407370601900127

Safety and trough concentrations of nevirapine prophylaxis given daily, twice weekly, or weekly in breast-feeding infants from birth to 6 months

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154407370601900127

Saliva and inhibition of HIV-1 infection: molecular mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154407370601900127

Two low doses of tenofovir protect newborn macaques against oral simian immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154407370601900127

Immunization of newborn rhesus macaques with simian immunodeficiency virus (SIV) vaccines prolongs survival after oral challenge with virulent SIVmac251.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154407370601900127

Per-contact risk of human immunodeficiency virus transmission between male sexual partners

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154407370601900127

Sexual practices and risk of infection by the human immunodeficiency virus. The San Francisco Men's Health Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154407370601900127

10.1177/154407370601900127

21 January 2018

Identifiers

DOI

1 reference

14 August 2017

1 reference